(Q43968387)

28 November 2017

title

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia (English)

1 reference

28 November 2017

3

1 reference

28 November 2017

21

1 reference

28 November 2017

S Thoene

8

0 references

Tobias Herold

object named as

T Herold

1

0 references

author name string

V Jurinovic

2

1 reference

28 November 2017

A-L Boulesteix

4

1 reference

28 November 2017

M Bergmann

5

1 reference

28 November 2017

T Seiler

6

1 reference

28 November 2017

M Mulaw

7

1 reference

28 November 2017

A Dufour

9

1 reference

28 November 2017

Z Pasalic

10

1 reference

28 November 2017

M Schmidberger

11

1 reference

28 November 2017

M Schmidt

12

1 reference

28 November 2017

S Schneider

13

1 reference

28 November 2017

P M Kakadia

14

1 reference

28 November 2017

M Feuring-Buske

15

1 reference

28 November 2017

J Braess

16

1 reference

28 November 2017

K Spiekermann

17

1 reference

28 November 2017

U Mansmann

18

1 reference

28 November 2017

W Hiddemann

19

1 reference

28 November 2017

C Buske

20

1 reference

28 November 2017

publication date

31 May 2011

1 reference

28 November 2017

1 reference

28 November 2017

volume

25

1 reference

28 November 2017

issue

10

1 reference

28 November 2017

page(s)

1639-1645

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2011.125

28 November 2017

exact match

0 references

cites work

De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

TP53 mutation and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.125

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2011.125

1 reference

Dimensions Publication ID

28 November 2017

1046214526

0 references

1 reference